{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:22Z","timestamp":1786119202161,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/iop.0b013e31817f526a","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:41:09Z","timestamp":1236267669000},"page":"299-301","source":"Crossref","is-referenced-by-count":16,"title":["Use of 0.5% Apraclonidine Solution in Evaluation of Blepharoptosis"],"prefix":"10.1097","volume":"24","author":[{"given":"B\u00fclent","family":"Yazc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmit","family":"Beden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archopht.1975.01010020595007","article-title":"Muller muscle-conjunctiva resection.","volume":"93","author":"Putterman","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9394(14)75239-0","article-title":"Possible adverse effects from topical ocular 10% phenylephrine.","volume":"85","author":"Fraunfelder","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(85)90371-X","article-title":"Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine.","volume":"99","author":"Fraunfelder","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R4-12-20210129","first-page":"173","article-title":"Comparison of 2.5% and 10% phenylephrine in the elevation of upper eyelids with ptosis.","volume":"21","author":"Glatt","year":"1990","journal-title":"Ophthalmic Surg"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.iop.0000167789.39570.3e","article-title":"Open sky Muller muscle-conjunctival resection in phenylephrine test-negative blepharoptosis patients.","volume":"21","author":"Baldwin","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00002341-199903000-00005","article-title":"Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid.","volume":"15","author":"Esmaeli-Gutstein","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/IOP.0b013e3181462a2e","article-title":"Adrenergic receptors in the ptotic human eyelid: correlation with phenylephrine testing and surgical success in ptosis repair.","volume":"23","author":"Skibell","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archopht.1987.01060090063028","article-title":"The safety and efficacy of topical 1% ALO2145 (p-aminoclonidine hydrochloride) in normal volunteers.","volume":"105","author":"Abrams","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archopht.121.8.1201","article-title":"The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome.","volume":"121","author":"Brown","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","article-title":"The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.","volume":"89","author":"Koc","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002341-199106000-00005","article-title":"Further modifications of the Muller\u2019s muscle-conjunctival resection procedure for blepharoptosis.","volume":"7","author":"Dresner","year":"1991","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0002-9394(14)76775-3","article-title":"Palpebral fissure responses to topical adrenergic drugs.","volume":"111","author":"Munden","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.iop.0000196322.05586.6a","article-title":"Effect of 0.5% apraclonidine on ptosis in Horner syndrome.","volume":"22","author":"Garibaldi","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0161-6420(92)31963-3","article-title":"Detection of contralateral eyelid retraction associated with blepharoptosis.","volume":"99","author":"Meyer","year":"1992","journal-title":"Ophthalmology"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08820530390895235","article-title":"Topical phenylephrine may result in worsening of visual loss when used to dilate pupils in patients with vaso-occlusive disease of the optic nerve.","volume":"18","author":"Pless","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.1990.01070110080029","article-title":"Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.","volume":"108","author":"Coleman","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00917987","article-title":"Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.","volume":"16","author":"Yuksel","year":"1992","journal-title":"Int Ophthalmol"},{"key":"R18-12-20210129","first-page":"421","article-title":"Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.","volume":"93","author":"Robin","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jaapos.2007.02.015","article-title":"Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.","volume":"11","author":"Watts","year":"2007","journal-title":"J AAPOS"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjo.85.1.99","article-title":"Repeatability and reproducibility of upper eyelid measurements.","volume":"85","author":"Boboridis","year":"2001","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IOP.0b013e31817f526a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:51Z","timestamp":1786038231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002341-200807000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e31817f526a","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}